Evidence map›Paper›PMID 34742305›Full record

ArticleCancer cell international2021

Circ-RNF121 regulates tumor progression and glucose metabolism by miR-1224-5p/FOXM1 axis in colorectal cancer.

Zhipeng Jiang, Hao Hu, Wenli Hu, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang, Shuang Chen

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. CircRNAs: emerging factors for regulating glucose metabolism in colorectal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhipeng Jiang *Department of Gastrointestinal Surgery, Laboratory of Colorectal and Pelvic Floor Diseases, Supported By National Key Clinical Discipline, Guangdong Institute of Gastroenterology, Guangdong Provincial Key, The Sixth Affiliated Hospital of Sun Yat-Sen University, No. 26 YuanCun, 2nd Heng Road, Guangzhou, 510655, Guangdong Province, China.
Hao Hu *Department of General Surgery, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
Wenli HuDepartment of Critical Care Medicine, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
Zehui HouDepartment of Gastrointestinal Surgery, Laboratory of Colorectal and Pelvic Floor Diseases, Supported By National Key Clinical Discipline, Guangdong Institute of Gastroenterology, Guangdong Provincial Key, The Sixth Affiliated Hospital of Sun Yat-Sen University, No. 26 YuanCun, 2nd Heng Road, Guangzhou, 510655, Guangdong Province, China.
Wei LiuDepartment of Gastrointestinal Surgery, Laboratory of Colorectal and Pelvic Floor Diseases, Supported By National Key Clinical Discipline, Guangdong Institute of Gastroenterology, Guangdong Provincial Key, The Sixth Affiliated Hospital of Sun Yat-Sen University, No. 26 YuanCun, 2nd Heng Road, Guangzhou, 510655, Guangdong Province, China.
Zhuomin YuDepartment of Gastrointestinal Surgery, Laboratory of Colorectal and Pelvic Floor Diseases, Supported By National Key Clinical Discipline, Guangdong Institute of Gastroenterology, Guangdong Provincial Key, The Sixth Affiliated Hospital of Sun Yat-Sen University, No. 26 YuanCun, 2nd Heng Road, Guangzhou, 510655, Guangdong Province, China.
Zhiqiang LiangDepartment of Gastrointestinal Surgery, Laboratory of Colorectal and Pelvic Floor Diseases, Supported By National Key Clinical Discipline, Guangdong Institute of Gastroenterology, Guangdong Provincial Key, The Sixth Affiliated Hospital of Sun Yat-Sen University, No. 26 YuanCun, 2nd Heng Road, Guangzhou, 510655, Guangdong Province, China.
Shuang ChenDepartment of Gastrointestinal Surgery, Laboratory of Colorectal and Pelvic Floor Diseases, Supported By National Key Clinical Discipline, Guangdong Institute of Gastroenterology, Guangdong Provincial Key, The Sixth Affiliated Hospital of Sun Yat-Sen University, No. 26 YuanCun, 2nd Heng Road, Guangzhou, 510655, Guangdong Province, China. jiangzhp5@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0002-2464-0702
Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimPrevious studies have reported that circular RNA (circRNA) is associated with the pathogenesis of CRC. This study was designed to reveal the mechanism of circ-ring finger protein 121 (circ-RNF121) in colorectal cancer (CRC). MATERIALS AND

methodsThe levels of circ-RNF121, microRNA-1224-5p (miR-1224-5p) and forkhead box M1 (FOXM1) were determined by quantitative real-time polymerase chain reaction (qRT-PCR). Protein level was detected by western blot. Cell proliferation was analyzed by 3-(4,5-Dimethylthazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and cell colony formation assays. Flow cytometry analysis was performed to investigate cell apoptosis. Cell migration and invasion were investigated by transwell and wound-healing assays. Cell glycolysis was detected using glucose, lactate and ADP/ATP ratio assay kits. The binding relationship between miR-1224-5p and circ-RNF121 or FOXM1 was predicted by starBase online database, and identified by dual-luciferase reporter assay. The impacts of circ-RNF121 silencing on tumor formation in vivo were disclosed by in vivo tumor formation assay. KEY

findingsCirc-RNF121 and FOXM1 expression were dramatically upregulated, while miR-1224-5p expression was downregulated in CRC tissues or cells compared with control groups. Circ-RNF121 silencing repressed cell proliferation, migration, invasion and glycolysis but induced cell apoptosis in CRC, which were attenuated by miR-1224-5p inhibitor. Additionally, circ-RNF121 acted as a sponge of miR-1224-5p and miR-1224-5p bound to FOXM1. Circ-RNF121 silencing inhibited tumor growth in vivo. Furthermore, circ-RNF121 was secreted through being packaged into exosomes. SIGNIFICANCE: The finding provided a novel insight into studying circRNA-mediated CRC therapy.

Identifiers

PMID34742305
PMCPMC8572430
OpenAlexW3211591770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.